(Q53276190)

12 May 2018

6 references

14 March 2019

22 March 2019

25 April 2019

17 June 2019

22 June 2019

7 November 2019

Deferoxamine therapy for intracerebral hemorrhage: A systematic review. (English)

1 reference

12 May 2018

6 references

14 March 2019

22 March 2019

25 April 2019

17 June 2019

22 June 2019

7 November 2019

1 reference

7 November 2019

1 reference

7 November 2019

1 reference

Jianwen Guo

6

0 references

author name string

Liling Zeng

1

1 reference

12 May 2018

Li Tan

2

1 reference

12 May 2018

Haijun Li

3

1 reference

12 May 2018

Qixin Zhang

4

1 reference

12 May 2018

Yongxian Li

5

1 reference

12 May 2018

language of work or name

English

0 references

publication date

22 March 2018

7 references

12 May 2018

14 March 2019

22 March 2019

25 April 2019

17 June 2019

22 June 2019

7 November 2019

7 references

12 May 2018

14 March 2019

22 March 2019

25 April 2019

17 June 2019

22 June 2019

7 November 2019

13

1 reference

12 May 2018

issue

3

1 reference

12 May 2018

page(s)

e0193615

1 reference

12 May 2018

Creative Commons Attribution 4.0 International

copyright license

6 references

14 March 2019

22 March 2019

25 April 2019

17 June 2019

22 June 2019

on focus list of Wikimedia project

7 November 2019

copyright status

copyrighted

0 references

ScienceSource

0 references

cites work

Mechanism and Therapy of Brain Edema after Intracerebral Hemorrhage

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5863956

Guidelines for the Management of Spontaneous Intracerebral Hemorrhage: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association

22 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5863956

Efficacy of deferoxamine in animal models of intracerebral hemorrhage: a systematic review and stratified meta-analysis

22 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5863956

The clinical effect of deferoxamine mesylate on edema after intracerebral hemorrhage

22 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5863956

High dose deferoxamine in intracerebral hemorrhage (HI-DEF) trial: rationale, design, and methods

22 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5863956

Safety and tolerability of deferoxamine mesylate in patients with acute intracerebral hemorrhage

22 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5863956

Treatment targets in intracerebral hemorrhage

22 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5863956

Advances in neuroprotective strategies: potential therapies for intracerebral hemorrhage

22 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5863956

Incidence, case fatality, and functional outcome of intracerebral haemorrhage over time, according to age, sex, and ethnic origin: a systematic review and meta-analysis

22 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5863956

Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement

22 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5863956

Intracerebral haemorrhage

22 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5863956

Effects of deferoxamine on intracerebral hemorrhage-induced brain injury in aged rats

22 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5863956

Deferoxamine therapy for intracerebral hemorrhage

22 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5863956

Deferoxamine mesylate: a new hope for intracerebral hemorrhage: from bench to clinical trials

22 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5863956

Association between serum ferritin level and perihematoma edema volume in patients with spontaneous intracerebral hemorrhage

22 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5863956

Association between C-reactive protein and recurrence of atrial fibrillation after successful electrical cardioversion: a meta-analysis

22 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5863956

Cardiac morbidity and mortality in deferoxamine- or deferiprone-treated patients with thalassemia major

22 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5863956

Mechanisms of brain injury after intracerebral haemorrhage.

22 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5863956

Iron and iron-handling proteins in the brain after intracerebral hemorrhage.

22 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5863956

Deferoxamine posttreatment reduces ischemic brain injury in neonatal rats.

22 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5863956

Ocular toxicity of desferrioxamine: light microscopic histochemical and ultrastructural findings

22 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5863956

Depletion of trace elements and acute ocular toxicity induced by desferrioxamine in patients with thalassaemia

22 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5863956

Desferrioxamine ototoxicity: evaluation of risk factors in thalassaemic patients and guidelines for safe dosage

22 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5863956

Hearing loss in Iranian thalassemia major patients treated with deferoxamine: A systematic review and meta-analysis.

22 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5863956

Olfactory dysfunction in β-thalassemia major patients treated with iron-chelating agents.

13 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5863956

In vivo efficacy, toxicity and biodistribution of ultra-long circulating desferrioxamine based polymeric iron chelator.

13 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5863956

Nephrolithiasis in patients exposed to deferasirox and desferioxamine: probably an age-linked event with different effects on some renal parameters

13 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5863956

13 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5863956

Brain edema after intracerebral hemorrhage in rats: the role of iron overload and aquaporin 4.

13 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5863956

13 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5863956

Growth Failure and Bony Changes Induced by Deferoxamine

30 November 2018

1 reference

12 December 2020

High-dose desferrioxamine as a cause of growth failure in thalassemic patients

1 reference

12 December 2020

Yersinia sepsis in patients with iron overload treated with deferoxamine

1 reference

12 December 2020

THE BIOCHEMISTRY OF DESFERRIOXAMINE AND ITS RELATION TO IRON METABOLISM

1 reference

12 December 2020

Iron--potential therapeutic target in hemorrhagic stroke

1 reference

12 December 2020

Intracerebral haemorrhage: no good treatment but treatment helps

1 reference

12 December 2020

10.1371/JOURNAL.PONE.0193615

Identifiers

DOI

1 reference

12 May 2018

PMC publication ID

5863956

1 reference

12 May 2018

PubMed publication ID

29566000

1 reference

12 May 2018